Bavarian Nordic AS (BAVA) - Financial and Strategic SWOT Analysis Review

June 2021 | 51 pages | ID: B021A5F5EA5EN
GlobalData

Abstracts

Bavarian Nordic AS (BAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bavarian Nordic A/S (Bavarian Nordic) develops, manufactures and commercializes vaccines for the treatment of life-threating diseases. The company develops its products using poxvirus-based technology platforms including modified vaccinia ankara – bavarian nordic (MVA-BN). The company’s marketed products include JYNNEOS for smallpox and monkeypox; Encepur for tick-borne encephalitis; MVABEA for ebola; and Rabipur/RabAvert for rabbies. Its pipeline products are intended for the treatment of smallpox, respiratory syncytial virus, COVID-19, HER2

and brachyury-expressing cancers and ebola infections. Bavarian Nordic has collaboration with US government and various institutes, to develop its product candidates for the treatment of cancer and infectious diseases. It has a presence in the US, Denmark, Switzerland and Germany. Bavarian Nordic is headquartered in Hellerup, Denmark.

Bavarian Nordic AS Key Recent Developments

Jun 02,2021: Bavarian Nordic Announces Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
May 27,2021: Bavarian Nordic Announces Interim Results for the First Three Months of 2021
Apr 20,2021: Bavarian Nordic Report on the Results of the Annual General Meeting held April 20 2021
Apr 06,2021: Bavarian Nordic receives order to manufacture additional Ebola vaccines
Mar 26,2021: Bavarian Nordic Announces the Resignation of Tommi Kainu as EVP and Chief Business Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Bavarian Nordic A/S - Key Facts
Bavarian Nordic A/S - Key Employees
Bavarian Nordic A/S - Key Employee Biographies
Bavarian Nordic A/S - Major Products and Services
Bavarian Nordic A/S - History
Bavarian Nordic A/S - Company Statement
Bavarian Nordic A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Bavarian Nordic A/S - Business Description
Product Category: Contract Work
Performance
Product Category: Encepur
Performance
Product Category: Milestone Payments
Performance
Product Category: MVA-BN Smallpox Vaccine Sale
Performance
Product Category: Rabipur/RabAvert
Performance
Geographical Segment: Austria
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other Geographic Markets
Performance
Geographical Segment: Sweden
Performance
Geographical Segment: Switzerland
Performance
Geographical Segment: The Netherlands
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
R&D Overview
Bavarian Nordic A/S - Corporate Strategy
Bavarian Nordic A/S - SWOT Analysis
SWOT Analysis - Overview
Bavarian Nordic A/S - Strengths
Bavarian Nordic A/S - Weaknesses
Bavarian Nordic A/S - Opportunities
Bavarian Nordic A/S - Threats
Bavarian Nordic A/S - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES

Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bavarian Nordic A/S, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 27, 2021: Bavarian Nordic Announces Interim Results for the First Three Months of 2021
Apr 20, 2021: Bavarian Nordic Report on the Results of the Annual General Meeting held April 20 2021
Apr 06, 2021: Bavarian Nordic receives order to manufacture additional Ebola vaccines
Mar 26, 2021: Bavarian Nordic Announces the Resignation of Tommi Kainu as EVP and Chief Business Officer
Mar 05, 2021: Bavarian Nordic to Host Full Year 2020 Results Conference Call
Jan 28, 2021: Bavarian Nordic reports preliminary financial results for 2020
Nov 11, 2020: Bavarian Nordic announces interim results for the first nine months of 2020
Oct 28, 2020: Bavarian Nordic adopting Veeva CRM and Veeva Vault PromoMats for digital launch of new vaccines
Oct 09, 2020: Bavarian Nordic announces appointment of Anu Helena Kerns as Executive Vice President, People and Organization
Sep 01, 2020: Bavarian Nordic announces the launch of distribution and marketing of Encepur and Rabipur in Germany

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Bavarian Nordic A/S, Key Facts
Bavarian Nordic A/S, Key Employees
Bavarian Nordic A/S, Key Employee Biographies
Bavarian Nordic A/S, Major Products and Services
Bavarian Nordic A/S, History
Bavarian Nordic A/S, Other Locations
Bavarian Nordic A/S, Subsidiaries
Bavarian Nordic A/S, Key Competitors
Bavarian Nordic A/S, Ratios based on current share price
Bavarian Nordic A/S, Annual Ratios
Bavarian Nordic A/S, Annual Ratios (Cont...1)
Bavarian Nordic A/S, Annual Ratios (Cont...2)
Bavarian Nordic A/S, Interim Ratios
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bavarian Nordic A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Bavarian Nordic A/S, Performance Chart (2016 - 2020)
Bavarian Nordic A/S, Ratio Charts
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021